Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections.
Infect Control Hosp Epidemiol. 2016 Jul 13;:1-7
Authors: Nelson RE, Schweizer ML, Perencevich EN, Nelson SD, Khader K, Ch…
Related ArticlesNosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Respirology. 2016 Feb;21(2):363-9
Authors: Özvatan T, Akalın H, Sınırtaş M, Ocakoğlu G, Yı…
Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China.
Am J Infect Control. 2016 Jan 21;
Authors: Guo N, Xue W, …
Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii.
Am J Infect Control. 2015 May 8;
Authors: Fu Q, Ye H, Liu S
Related ArticlesEfficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
Antimicrob Agents Chemother. 2015 Mar 30;
Authors: Liou BH, Lee YT, Kuo SC, Liu PY, Fung CP
Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
Int J Antimicrob Agents. 2015 Feb 16;
Authors: Falagas ME, Vardakas KZ, Kapaskelis A, Triarides NA, Roussos NS